Patents/Assignees

Reveragen Biopharma, Inc.

3 patents in portfolio

US12201639utility2025
Aqueous Oral Pharmaceutical Suspension Compositions
0 cites
US11833159utility2023
Non-hormonal Steroid Modulators of Nf-kb for Treatment of Disease
0 cites
US11690853utility2023
Non-hormonal Steroid Modulators of Nf-κβ for Treatment of Disease
0 cites